Related Experiment Video

Updated: Jun 29, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Azithromycin does not prevent six-month myointimal proliferation but attenuates the transient systemic inflammation

Dimas T Ikeoka1, Carolina Z Vieira, Pedro A Lemos

  • 1Center for Medical Research and Clinical Institute for Medical and Chemical Laboratory Diagnostics, Medical University Graz, Stiftingtalstrasse, 24, 8010, Graz, Austria.

Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|October 15, 2008
PubMed

Insights

Antibiotic azithromycin did not improve stent outcomes but reduced C-reactive protein elevation post-procedure. This suggests an anti-inflammatory effect of azithromycin in patients undergoing stenting.

Area of Science:

  • Cardiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Stent implantation can trigger systemic inflammation, potentially linked to Chlamydophila pneumoniae.
  • Inflammatory markers rise post-stenting, impacting patient outcomes.

Purpose of the Study:

  • To investigate the effect of azithromycin on 6-month angiographic outcomes after stenting.
  • To assess the anti-inflammatory impact of antibiotic treatment in atherosclerotic patients.

Main Methods:

  • A double-blinded, randomized study assigned 90 patients to oral azithromycin or placebo.
  • Medication was given pre-stenting and continued for 12 weeks post-procedure.
  • Angiographic and laboratorial parameters were assessed at multiple time points up to 6 months.

Main Results:

  • No significant differences were observed in minimal luminal diameter, restenosis, or stenosis rates between groups at 6 months.
  • Serum C-reactive protein significantly increased in the placebo group post-stenting but remained stable in the azithromycin group.

Conclusions:

  • Azithromycin does not improve late angiographic outcomes following stenting.
  • Azithromycin attenuates the post-stenting increase in C-reactive protein, demonstrating an anti-inflammatory effect.
Abstract

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...